Moleculin Biotech (MBRX) Insider Trading & Ownership $1.06 -0.09 (-7.39%) Closing price 03:59 PM EasternExtended Trading$1.05 -0.01 (-1.41%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Moleculin Biotech (NASDAQ:MBRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.10%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$326,109.30Number OfInsiders Selling(Last 3 Years)0 Get MBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MBRX Insider Buying and Selling by Quarter Moleculin Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/26/2023Jonathan P FosterCFOBuy1,932$10.35$19,996.20 12/26/2023Robert E GeorgeDirectorBuy966$10.35$9,998.10 12/26/2023Walter V KlempCEOBuy12,560$10.35$129,996.00 11/25/2022Walter V KlempCEOBuy3,000$19.20$57,600.00 11/21/2022Walter V KlempCEOBuy1,500$17.25$25,875.00 11/16/2022Walter V KlempCEOBuy5,680$14.55$82,644.00 (Data available from 1/1/2013 forward) MBRX Insider Trading Activity - Frequently Asked Questions Who is on Moleculin Biotech's Insider Roster? The list of insiders at Moleculin Biotech includes Jonathan P Foster, Robert E George, and Walter V Klemp. Learn more on insiders at MBRX. What percentage of Moleculin Biotech stock is owned by insiders? 7.10% of Moleculin Biotech stock is owned by insiders. Learn more on MBRX's insider holdings. Which Moleculin Biotech insiders have been buying company stock? The following insiders have purchased MBRX shares in the last 24 months: Jonathan P Foster ($19,996.20), Robert E George ($9,998.10), and Walter V Klemp ($129,996.00). How much insider buying is happening at Moleculin Biotech? Insiders have purchased a total of 15,458 MBRX shares in the last 24 months for a total of $159,990.30 bought. Moleculin Biotech Key ExecutivesMr. Walter V. Klemp (Age 64)Founder, Chairman, President & CEO Compensation: $894.54kMr. Jonathan P. Foster CPA (Age 60)Executive VP & CFO Compensation: $611.17kDr. Donald H. Picker Ph.D. (Age 78)Chief Scientific Officer Compensation: $486.44kDr. Waldemar Priebe Ph.D.Co-Founder, Founding Scientist & Chairman of Scientific Advisory BoardDr. John Paul Waymack M.D. (Age 72)Sc.D., Senior Chief Medical Officer Dr. Sandra L. Silberman M.D. (Age 69)Ph.D., Chief Medical Officer of New Products Dr. Wolfram C. M. Dempke M.B.A.M.D., Ph.D., European Chief Medical OfficerMs. Jacqueline Northcut (Age 62)Consultant Compensation: $51.11kMr. Louis Ploth Jr. (Age 70)Independent Advisor Compensation: $118.49k More Insider Trading Tools from MarketBeat Related Companies MEI Pharma Insider Ownership Spruce Biosciences Insider Ownership Marker Therapeutics Insider Ownership MIRA Pharmaceuticals Insider Ownership BriaCell Therapeutics Insider Ownership Lipocine Insider Ownership HCW Biologics Insider Ownership Synlogic Insider Ownership Tonix Pharmaceuticals Insider Ownership Athira Pharma Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:MBRX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moleculin Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
